Open-Angle Glaucoma: A Patient Guide
At a Glance
Open-angle glaucoma often damages the optic nerve without early warning symptoms. Regular eye exams and OCT imaging can detect change, while lowering eye pressure with drops or selective laser trabeculoplasty helps slow progression and preserve remaining vision.
Open-angle glaucoma is a chronic condition characterized by a slow, progressive breakdown in the eye’s natural drainage system. In a healthy eye, a clear fluid called aqueous humor is constantly produced and drained to maintain a stable internal environment. In patients with this condition, the “drainage angle” between the iris and the cornea remains physically open, but the microscopic filters within that angle—the trabecular meshwork—become increasingly resistant to fluid flow [1][2]. This resistance causes fluid to back up, which can lead to a buildup of pressure that places physical and metabolic stress on the optic nerve, the vital cable connecting the eye to the brain [3].
This condition is often referred to as a “silent” disease because it typically produces no pain, redness, or immediate blurring of vision. Because the initial damage often occurs in the peripheral (side) vision, the brain and the other eye can compensate for small gaps in sight, leaving the person unaware of the problem until it reaches an advanced stage [4][5]. However, it is important to note that normal-tension glaucoma can sometimes produce central or paracentral vision defects relatively early on. This is why regular eye examinations and advanced imaging, such as Optical Coherence Tomography (OCT) scans, are essential; they allow doctors to detect structural thinning of the nerve fibers long before a patient experiences any functional change in their vision [6].
The current medical standard of care is focused on slowing the rate or reducing the risk of progression by lowering intraocular pressure (IOP). Even for patients whose eye pressure is technically within the statistical “normal” range—a variant known as normal-tension glaucoma—further reducing that pressure is the most established method to protect the remaining nerve fibers [7][8]. Treatment typically begins with daily eye drops or a gentle, in-office laser procedure called Selective Laser Trabeculoplasty (SLT), both of which aim to improve fluid drainage or reduce fluid production [9][10].
While receiving a glaucoma diagnosis is a serious event, it is important to know that treatment preserves remaining vision, even though it cannot restore nerve fibers that have already been lost. The disease usually moves slowly, but individual prognosis depends heavily on the stage at diagnosis, the glaucoma subtype (for example, pseudoexfoliative disease may be more aggressive), your rate of progression, and how well you respond to treatment [11]. Many people who are diagnosed with open-angle glaucoma will retain functional, useful vision for the rest of their lives, provided they consistently follow their treatment plan and attend all scheduled monitoring appointments [12][13]. By taking a proactive role in your care and maintaining open communication with your medical team, you can effectively manage the condition and protect your sight for the future.
In this guide
6 chapters
Understanding Your Diagnosis
Learn what an open-angle glaucoma diagnosis means, how eye pressure and optic nerve damage are assessed, who is at risk, and how treatment helps protect vision.
Biology & Types of Open-Angle Glaucoma
Learn how open-angle glaucoma affects eye drainage and the optic nerve, including POAG, normal-tension, pseudoexfoliative, pigmentary, and steroid-induced types.
Diagnostic Tests & Monitoring
Learn how open-angle glaucoma is diagnosed and monitored with gonioscopy, OCT, visual field testing, eye pressure checks, and optic nerve exams over time.
Standard Treatment: Drops & Laser (SLT)
Learn how eye drops and selective laser trabeculoplasty (SLT) treat open-angle glaucoma. Compare target IOP, side effects, benefits, risks, and follow-up.
Surgical Treatment: MIGS, Trabeculectomy & Tubes
Learn about open-angle glaucoma surgery, including MIGS, trabeculectomy, and tube shunts, and understand indications, risks, recovery, and follow-up care.
Living with Glaucoma & Warning Signs
Learn how to live with open-angle glaucoma, use eye drops correctly, protect daily independence, manage scan anxiety, and recognize urgent warning signs.
Common questions in this guide
Why can open-angle glaucoma be difficult to notice?
Can I have glaucoma even if my eye pressure is in the normal range?
How is open-angle glaucoma found before I notice vision loss?
What treatments are used to slow open-angle glaucoma?
Can glaucoma treatment restore vision that has already been lost?
How will my doctor know if my glaucoma is progressing?
Should my first-degree relatives be screened for glaucoma?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the current stage of my glaucoma in each eye based on my baseline tests?
- 2.What is my 'target eye pressure,' and how frequently will we need to check it to ensure my treatment is working?
- 3.Is my optic nerve damage likely caused by high eye pressure, or do I have 'normal-tension' glaucoma?
- 4.Are there specific lifestyle changes or medication adjustments I should discuss with my other doctors?
- 5.How will we know if my glaucoma is progressing even if my eye pressure remains within the target range?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
The exit strategy: Pharmacological modulation of extracellular matrix production and deposition for better aqueous humor drainage.
Pattabiraman PP, Toris CB
European journal of pharmacology 2016; (787()):32-42.
PMID: 27112663 - 2
Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways.
Tamm ER, Braunger BM, Fuchshofer R
Progress in molecular biology and translational science 2015; (134()):301-14.
PMID: 26310162 - 3
Impaired axonal transport contributes to neurodegeneration in a Cre-inducible mouse model of myocilin-associated glaucoma.
Kaipa BR, Kasetti R, Sundaresan Y, et al.
JCI insight 2025; (10(5)).
PMID: 39836483 - 4
Primary open-angle glaucoma.
Weinreb RN, Leung CK, Crowston JG, et al.
Nature reviews. Disease primers 2016; (2()):16067 doi:10.1038/nrdp.2016.67.
PMID: 27654570 - 5
Advanced glaucoma at diagnosis: current perspectives.
Kastner A, King AJ
Eye (London, England) 2020; (34(1)):116-128 doi:10.1038/s41433-019-0637-2.
PMID: 31740802 - 6
Patterns of Progressive Ganglion Cell-Inner Plexiform Layer Thinning in Glaucoma Detected by OCT.
Shin JW, Sung KR, Park SW
Ophthalmology 2018; (125(10)):1515-1525 doi:10.1016/j.ophtha.2018.03.052.
PMID: 29705057 - 7
Treatment choices for newly diagnosed primary open angle and ocular hypertension patients.
Garg A, Gazzard G
Eye (London, England) 2020; (34(1)):60-71 doi:10.1038/s41433-019-0633-6.
PMID: 31685971 - 8
What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews.
Qureshi R, Azuara-Blanco A, Michelessi M, et al.
Ophthalmology. Glaucoma 2021; (4(5)):454-462 doi:10.1016/j.ogla.2021.01.007.
PMID: 33571689 - 9
A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".
Sarenac T, Bečić Turkanović A, Ferme P, Gračner T
Journal of clinical medicine 2022; (11(13)) doi:10.3390/jcm11133879.
PMID: 35807163 - 10
Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.
Klimko PG, Sharif NA
British journal of pharmacology 2019; (176(8)):1051-1058 doi:10.1111/bph.14327.
PMID: 29665040 - 11
Long Term Results of Visual Field Progression Analysis in Open Angle Glaucoma Patients Under Treatment.
Kocatürk T, Bekmez S, Katrancı M, et al.
The open ophthalmology journal 2015; (9()):116-20 doi:10.2174/1874364101509010116.
PMID: 26311586 - 12
The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study.
Baskaran M, Foo RC, Cheng CY, et al.
JAMA ophthalmology 2015; (133(8)):874-80 doi:10.1001/jamaophthalmol.2015.1110.
PMID: 25974263 - 13
Topical Medication Adherence and Visual Field Progression in Open-angle Glaucoma: Analysis of a Large US Health Care System.
Shu YH, Wu J, Luong T, et al.
Journal of glaucoma 2021; (30(12)):1047-1055 doi:10.1097/IJG.0000000000001943.
PMID: 34669680
This page explains open-angle glaucoma, its monitoring, and treatment options for informational purposes only and does not constitute medical advice. Ask your ophthalmologist to interpret your eye pressure, test results, and treatment plan.
Get notified when new evidence is published on open-angle glaucoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.